Catalyst Biosciences (CBIO) Competitor Comparison
We are evaluating the key criteria listed to compare Catalyst Biosciences (CBIO) against its competitors in the Biotechnology industry.
Market Capitalization
329 / 368Gross Profits
0 / 278Total Revenue
290 / 300EBITDA
63 / 337Free Cashflow
57 / 352Quick Ratio
294 / 357Earnings per Share
351 / 359Dividend yield
1 / 6Total Cash
343 / 358Performance 3 years
70 / 368Performance 5 years
131 / 368Performance 10 years
319 / 368Linearity 3 years
191 / 368Linearity 5 years
126 / 368Linearity 10 years
304 / 367Total Rank
77 / 368Dividend Rank
34 / 368Valuation Rank
331 / 368Piotroski Rank
139 / 368Muliplier Rank
306 / 368Market Capitalization - CBIO ranking 329 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.